Congenital varicella syndrome

Last updated

Congenital varicella syndrome is a rare disease resulting from Varicella Zoster virus (VZV) infection during the period of gestation. Viremia during the primary infection can result in transplacental transmission of the infection to the developing fetus. An estimated 25% of fetuses get infected with varicella infection when mother has a varicella infection during the pregnancy but the risk of developing congenital varicella syndrome is around 2%, therefore majority of the outcomes are normal newborns. Patients with primary infection before 20 weeks of gestation are at a higher risk of developing the severe form of infection, affecting the eyes, limbs, skin and the central nervous system. Diagnosis requires a documented history of primary infection in the mother and serial ultrasound demonstrating features suggestive of congenital varicella syndrome. There is no definitive treatment, termination of pregnancy in fetuses with severe features is recommended. Vaccination to prevent maternal varicella infection and proper counseling to avoid contact with infected people are important for the management options to reduce the incidence of congenital varicella syndrome. [1]

Contents

Historical perspective

Classification

There is no classification for congenital varicella syndrome.

Pathophysiology

Pathogenesis

Epidemiology and demographics

Congenital varicella syndrome is a rare disease with over 100 cases reported in literature. [12]

Causes

Congenital varicella syndrome is caused by Varicella zoster virus (VZV), a human alpha herpes virus.

Differentiating congenital varicella syndrome from other diseases

The most important congenital infections, which can be transmitted vertically from mother to fetus are the TORCH infections. These infections have overlapping features and hence, must be differentiated from congenital varicella syndrome: [13] [14]

Congenital InfectionCardiac FindingsSkin FindingsOcular FindingsHepatosplenomegaly Hydrocephalus Microcephaly Intracranial calcifications Hearing deficits
Congenital Varicella syndrome-
  • Cicatrical Skin Lesions
  • Skin edema
Toxoplasmosis Diffuse intracranial calcifications
Congenital Syphilis
Rubella
Cytomegalovirus (CMV)Periventricular calcifications
Herpes simplex virus
Parvovirus B19

Natural history, prognosis and complications

Natural history

VZV infection during pregnancy results in a normal newborn birth in majority of the patients, however, in a few patients it can result in congenital varicella syndrome or neonatal varicella or clinical zoster during infancy, the outcomes are dependent on the gestational age of fetus at the time of infection. Early gestational period infection via the transplacental route can result in congenital varicella syndrome resulting in a miscarriage, abortion or a newborn with features affecting the limbs, eyes, central nervous system, autonomic nervous system and present with features such as low birth weight, cutaneous scarring, limb hypoplasia, microcephaly, cortical atrophy, chorioretinitis and cataracts. [15] [16]

Prognosis

Severe infection of the fetus can result in an abortion. Infants born with signs of congenital varicella syndrome have poor prognosis and die during the first few months of life. [17] [15] Infants with milder symptoms can have a normal development and good prognosis. [18] [19]

Complications

Congenital varicella infection can result in the following complications: [20]

Diagnosis

History and symptoms

Symptoms of primary infection in mother :

Symptoms in the neonate

Physical examination

Physical examination findings suggestive of congenital varicella syndrome include: [25] [26]

Physical examination findings in congenital varicella syndrome
Skin
  • Cicatricial lesions( Zig-Zag scarring in dermatomal distribution) [27]
  • Hypopigmentation
Eye
Central Nervous System
Musculoskeletal system
  • Limb hypoplasia
  • Muscle hypoplasia
Systemic Manifestations

Table adopted from varicella in fetus and newborn [31]

Laboratory findings

The diagnosis of congenital varicella syndrome is based on a documented history of varicella infection during the pregnancy and the presence of fetal manifestations on ultrasound. [32]

Key findings for diagnosis of congenital varicella syndrome
History
Fetus / Neonatal Findings
  • Presence of characteristic cicatrical skin lesions, eye lesions, neurological deficits, limb abnormalities
Proof of Intrauterine Varicella infection

Table adopted from Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections [33]

Diagnosis of primary infection in the mother : In pregnant women diagnosis of a primary infection requires a combination of clinical manifestations and series of diagnostic tests. The tests are performed on the samples from the vesicular skin lesions and include the following:

Prenatal diagnosis

Imaging studies

Ultrasound

MRI

Prenatal MRI is a useful investigation to assess the extent of CNS involvement and to confirm the findings of ultrasound. [40]

Postnatal diagnosis

Treatment

Medical therapy

Surgical therapy

There are no surgical therapies for treatment of congenital varicella syndrome.

Prevention

Primary prevention

Secondary prevention

Related Research Articles

<span class="mw-page-title-main">Congenital rubella syndrome</span> Medical condition

Congenital rubella syndrome (CRS) occurs when a human fetus is infected with the rubella virus via maternal-fetal transmission and develops birth defects. The most common congenital defects affect the ophthalmologic, cardiac, auditory, and neurologic systems.

<span class="mw-page-title-main">Amniocentesis</span> Sampling of amniotic fluid done mainly to detect fetal chromosomal abnormalities

Amniocentesis is a medical procedure used primarily in the prenatal diagnosis of genetic conditions. It has other uses such as in the assessment of infection and fetal lung maturity. Prenatal diagnostic testing, which includes amniocentesis, is necessary to conclusively diagnose the majority of genetic disorders, with amniocentesis being the gold-standard procedure after 15 weeks' gestation.

<span class="mw-page-title-main">Varicella zoster virus</span> Herpes virus that causes chickenpox and shingles

Varicella zoster virus (VZV), also known as human herpesvirus 3 or Human alphaherpesvirus 3 (taxonomically), is one of nine known herpes viruses that can infect humans. It causes chickenpox (varicella) commonly affecting children and young adults, and shingles in adults but rarely in children. As a late complication of VZV infection, Ramsay Hunt syndrome type 2 may develop in rare cases. VZV infections are species-specific to humans. The virus can survive in external environments for a few hours.

<span class="mw-page-title-main">Fifth disease</span> Red rash due to infection with parvovirus B19

Fifth disease, also known as erythema infectiosum and slapped cheek syndrome, is a common and contagious disease caused by infection with parvovirus B19. This virus was discovered in 1975 and can cause other diseases besides fifth disease. Fifth disease typically presents as a rash and is most common in children. While parvovirus B19 can affect people of all ages, only two out of ten individuals will present with symptoms.

<span class="mw-page-title-main">Prenatal testing</span> Testing for diseases or conditions in a fetus

Prenatal testing is a tool that can be used to detect some birth defects at various stages prior to birth. Prenatal testing consists of prenatal screening and prenatal diagnosis, which are aspects of prenatal care that focus on detecting problems with the pregnancy as early as possible. These may be anatomic and physiologic problems with the health of the zygote, embryo, or fetus, either before gestation even starts or as early in gestation as practicable. Screening can detect problems such as neural tube defects, chromosome abnormalities, and gene mutations that would lead to genetic disorders and birth defects, such as spina bifida, cleft palate, Down syndrome, trisomy 18, Tay–Sachs disease, sickle cell anemia, thalassemia, cystic fibrosis, muscular dystrophy, and fragile X syndrome. Some tests are designed to discover problems which primarily affect the health of the mother, such as PAPP-A to detect pre-eclampsia or glucose tolerance tests to diagnose gestational diabetes. Screening can also detect anatomical defects such as hydrocephalus, anencephaly, heart defects, and amniotic band syndrome.

<span class="mw-page-title-main">Polyhydramnios</span> Excess of amniotic fluid in the amniotic sac

Polyhydramnios is a medical condition describing an excess of amniotic fluid in the amniotic sac. It is seen in about 1% of pregnancies. It is typically diagnosed when the amniotic fluid index (AFI) is greater than 24 cm. There are two clinical varieties of polyhydramnios: chronic polyhydramnios where excess amniotic fluid accumulates gradually, and acute polyhydramnios where excess amniotic fluid collects rapidly.

Oligohydramnios is a medical condition in pregnancy characterized by a deficiency of amniotic fluid, the fluid that surrounds the fetus in the abdomen, in the amniotic sac. The limiting case is anhydramnios, where there is a complete absence of amniotic fluid. It is typically diagnosed by ultrasound when the amniotic fluid index (AFI) measures less than 5 cm or when the single deepest pocket (SDP) of amniotic fluid measures less than 2 cm. Amniotic fluid is necessary to allow for normal fetal movement, lung development, and cushioning from uterine compression. Low amniotic fluid can be attributed to a maternal, fetal, placental or idiopathic cause and can result in poor fetal outcomes including death. The prognosis of the fetus is dependent on the etiology, gestational age at diagnosis, and the severity of the oligohydramnios.

The triple test, also called triple screen, the Kettering test or the Bart's test, is an investigation performed during pregnancy in the second trimester to classify a patient as either high-risk or low-risk for chromosomal abnormalities.

<span class="mw-page-title-main">Hemolytic disease of the newborn</span> Fetal and neonatal alloimmune blood condition

Hemolytic disease of the newborn, also known as hemolytic disease of the fetus and newborn, HDN, HDFN, or erythroblastosis fetalis, is an alloimmune condition that develops in a fetus at or around birth, when the IgG molecules produced by the mother pass through the placenta. Among these antibodies are some which attack antigens on the red blood cells in the fetal circulation, breaking down and destroying the cells. The fetus can develop reticulocytosis and anemia. The intensity of this fetal disease ranges from mild to very severe, and fetal death from heart failure can occur. When the disease is moderate or severe, many erythroblasts are present in the fetal blood, earning these forms of the disease the name erythroblastosis fetalis.

<span class="mw-page-title-main">Hydrops fetalis</span> Accumulation of fluid in at least two fetal compartments

Hydrops fetalis or hydrops foetalis is a condition in the fetus characterized by an accumulation of fluid, or edema, in at least two fetal compartments. By comparison, hydrops allantois or hydrops amnion is an accumulation of excessive fluid in the allantoic or amniotic space, respectively.

<span class="mw-page-title-main">Vertically transmitted infection</span> Infection caused by pathogens that use mother-to-children transmission

A vertically transmitted infection is an infection caused by pathogenic bacteria or viruses that use mother-to-child transmission, that is, transmission directly from the mother to an embryo, fetus, or baby during pregnancy or childbirth. It can occur when the mother has a pre-existing disease or becomes infected during pregnancy. Nutritional deficiencies may exacerbate the risks of perinatal infections. Vertical transmission is important for the mathematical modelling of infectious diseases, especially for diseases of animals with large litter sizes, as it causes a wave of new infectious individuals.

<i>Fetal surgery</i> Growing branch of maternal-fetal medicine

Fetal surgery, also known as antenatal surgery or prenatal surgery, is a growing branch of maternal-fetal medicine that covers any of a broad range of surgical techniques that are used to treat congenital abnormalities in fetuses who are still in the pregnant uterus. There are three main types: open fetal surgery, which involves completely opening the uterus to operate on the fetus; minimally invasive fetoscopic surgery, which uses small incisions and is guided by fetoscopy and sonography; and percutaneous fetal therapy, which involves placing a catheter under continuous ultrasound guidance.

<span class="mw-page-title-main">Nuchal scan</span> Routine ultrasound done between 11 and 14 weeks pregnancy

A nuchal scan or nuchal translucency (NT) scan/procedure is a sonographic prenatal screening scan (ultrasound) to detect chromosomal abnormalities in a fetus, though altered extracellular matrix composition and limited lymphatic drainage can also be detected.

<span class="mw-page-title-main">Maternal–fetal medicine</span> Branch of medicine

Maternal–fetal medicine (MFM), also known as perinatology, is a branch of medicine that focuses on managing health concerns of the mother and fetus prior to, during, and shortly after pregnancy.

<span class="mw-page-title-main">Percutaneous umbilical cord blood sampling</span>

Percutaneous umbilical cord blood sampling (PUBS), also called cordocentesis, fetal blood sampling, or umbilical vein sampling is a diagnostic genetic test that examines blood from the fetal umbilical cord to detect fetal abnormalities. Fetal and maternal blood supply are typically connected in utero with one vein and two arteries to the fetus. The umbilical vein is responsible for delivering oxygen rich blood to the fetus from the mother; the umbilical arteries are responsible for removing oxygen poor blood from the fetus. This allows for the fetus’ tissues to properly perfuse. PUBS provides a means of rapid chromosome analysis and is useful when information cannot be obtained through amniocentesis, chorionic villus sampling, or ultrasound ; this test carries a significant risk of complication and is typically reserved for pregnancies determined to be at high risk for genetic defect. It has been used with mothers with immune thrombocytopenic purpura.

<span class="mw-page-title-main">Chickenpox</span> Human viral disease

Chickenpox, also known as varicella, is a highly contagious, vaccine-preventable disease caused by the initial infection with varicella zoster virus (VZV), a member of the herpesvirus family. The disease results in a characteristic skin rash that forms small, itchy blisters, which eventually scab over. It usually starts on the chest, back, and face. It then spreads to the rest of the body. The rash and other symptoms, such as fever, tiredness, and headaches, usually last five to seven days. Complications may occasionally include pneumonia, inflammation of the brain, and bacterial skin infections. The disease is usually more severe in adults than in children.

Immune tolerance in pregnancy or maternal immune tolerance is the immune tolerance shown towards the fetus and placenta during pregnancy. This tolerance counters the immune response that would normally result in the rejection of something foreign in the body, as can happen in cases of spontaneous abortion. It is studied within the field of reproductive immunology.

<span class="mw-page-title-main">Congenital cytomegalovirus infection</span> Medical condition

Congenital cytomegalovirus (cCMV) is cytomegalovirus (CMV) infection in a newborn baby. Most have no symptoms. Some affected babies are small. Other signs and symptoms include a rash, jaundice, hepatomegaly, retinitis, and seizures. It may lead to loss of hearing or vision, developmental disability, or a small head.

<span class="mw-page-title-main">High-risk pregnancy</span> Medical condition

A high-risk pregnancy is a pregnancy where the mother or the fetus has an increased risk of adverse outcomes compared to uncomplicated pregnancies. No concrete guidelines currently exist for distinguishing “high-risk” pregnancies from “low-risk” pregnancies; however, there are certain studied conditions that have been shown to put the mother or fetus at a higher risk of poor outcomes. These conditions can be classified into three main categories: health problems in the mother that occur before she becomes pregnant, health problems in the mother that occur during pregnancy, and certain health conditions with the fetus.

Limb body wall complex (LBWC) is a rare and severe syndrome of congenital malformations involving craniofacial and abdominal anomalies. LBWC emerges during early fetal development and is fatal. The cause of LBWC is unknown.

References

Creative Commons by-sa small.svg  This article incorporates textby Mahshid Mir, Usama Talib, Aravind Reddy Kuchkuntla, Aditya Ganti, Michael Maddaleni and Kalsang Dolma available under the CC BY-SA 3.0 license.

  1. Mahshid Mir; Usama Talib; Aravind Reddy Kuchkuntla; Michael Maddaleni; Kalsang Dolma, "Congenital Varicella syndrome", wikidoc , retrieved 2024-07-24
  2. Laforet, Eugene G.; Lynch, Charles L. (1947). "Multiple Congenital Defects Following Maternal Varicella". New England Journal of Medicine. 236 (15): 534–537. doi:10.1056/NEJM194704102361504. ISSN   0028-4793.
  3. McKendry JB, Bailey JD (1973). "Congenital varicella associated with multiple defects". Can Med Assoc J. 108 (1): 66–8. PMC   1941110 . PMID   4682642.
  4. Paryani, Sharon G.; Arvin, Ann M. (1986). "Intrauterine Infection with Varicella-Zoster Virus after Maternal Varicella". New England Journal of Medicine. 314 (24): 1542–1546. doi:10.1056/NEJM198606123142403. ISSN   0028-4793.
  5. Brice JE (1976). "Congenital varicella resulting from infection during second trimester of pregnancy". Arch Dis Child. 51 (6): 474–6. PMC   1546018 . PMID   942245.
  6. Pastuszak, Anne L.; Levy, Maurice; Schick, Betsy; Zuber, Carol; Feldkamp, Marcia; Gladstone, Johnathan; Bar-Levy, Fanny; Jackson, Elaine; Donnenfeld, Alan; Meschino, Wendy; Koren, Gideon (1994). "Outcome after Maternal Varicella Infection in the First 20 Weeks of Pregnancy". New England Journal of Medicine. 330 (13): 901–905. doi:10.1056/NEJM199403313301305. ISSN   0028-4793.
  7. 1 2 Tan MP, Koren G (2006). "Chickenpox in pregnancy: revisited". Reprod Toxicol. 21 (4): 410–20. doi:10.1016/j.reprotox.2005.04.011. PMID   15979274.
  8. Higa K, Dan K, Manabe H (1987). "Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformations". Obstet Gynecol. 69 (2): 214–22. PMID   3027637.
  9. Grose C (1989). "Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity". Mol Biol Med. 6 (5): 453–62. PMID   2560525.
  10. Nikkels AF, Delbecque K, Pierard GE, Wienkotter B, Schalasta G, Enders M (2005). "Distribution of varicella-zoster virus DNA and gene products in tissues of a first-trimester varicella-infected fetus". J Infect Dis. 191 (4): 540–5. doi:10.1086/426942. PMID   15655777.
  11. 1 2 Rigsby CK, Donnelly LF (1997). "Fetal varicella syndrome: association with multiple hepatic calcifications and intestinal atresia". Pediatr Radiol. 27 (9): 779. doi:10.1007/s002470050229. PMID   9285750.
  12. Satti, Komal Fayyaz; Ali, Syed Asad; Weitkamp, Jörn-Hendrik (2010). "Congenital Infections, Part 2: Parvovirus, Listeria, Tuberculosis, Syphilis, and Varicella". NeoReviews. 11 (12): e681–e695. doi:10.1542/neo.11-12-e681. ISSN   1526-9906.
  13. Neu N, Duchon J, Zachariah P (2015). "TORCH infections". Clin Perinatol. 42 (1): 77–103, viii. doi:10.1016/j.clp.2014.11.001. PMID   25677998.
  14. Ajij M, Nangia S, Dubey BS (2014). "Congenital rubella syndrome with blueberry muffin lesions and extensive metaphysitis". J Clin Diagn Res. 8 (12): PD03–4. doi:10.7860/JCDR/2014/10271.5293. PMC   4316306 . PMID   25654000.
  15. 1 2 Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M (1994). "Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases". Lancet. 343 (8912): 1548–51. PMID   7802767.
  16. Frey HM, Bialkin G, Gerson AA (1977). "Congenital varicella: case report of a serologically proved long-term survivor". Pediatrics. 59 (1): 110–2. PMID   402633.
  17. Sauerbrei A, Wutzler P (2000). "The congenital varicella syndrome". J Perinatol. 20 (8 Pt 1): 548–54. PMID   11190597.
  18. Kotchmar GS, Grose C, Brunell PA (1984). "Complete spectrum of the varicella congenital defects syndrome in 5-year-old child". Pediatr Infect Dis. 3 (2): 142–5. PMID   6328456.
  19. Schulze A, Dietzsch HJ (2000). "The natural history of varicella embryopathy: a 25-year follow-up". J Pediatr. 137 (6): 871–4. doi:10.1067/mpd.2000.109005. PMID   11113846.
  20. Savage MO, Moosa A, Gordon RR (1973). "Maternal varicella infection as a cause of fetal malformations". Lancet. 1 (7799): 352–4. PMID   4121940.
  21. Katz VL, Kuller JA, McMahon MJ, Warren MA, Wells SR (1995). "Varicella during pregnancy. Maternal and fetal effects". West J Med. 163 (5): 446–50. PMC   1303168 . PMID   8533407.
  22. Sauerbrei A, Wutzler P (2007). "Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections". Med Microbiol Immunol. 196 (2): 95–102. doi:10.1007/s00430-006-0032-z. PMID   17180380.
  23. Andreou A, Basiakos H, Hatzikoumi I, Lazarides A (1995). "Fetal varicella syndrome with manifestations limited to the eye". Am J Perinatol. 12 (5): 347–8. doi:10.1055/s-2007-994493. PMID   8540940.
  24. Alexander I (1979). "Congenital varicella". Br Med J. 2 (6197): 1074. PMC   1596860 . PMID   519294.
  25. Magliocco AM, Demetrick DJ, Sarnat HB, Hwang WS (1992). "Varicella embryopathy". Arch Pathol Lab Med. 116 (2): 181–6. PMID   1733414.
  26. Mendívil A, Mendívil MP, Cuartero V (1992). "Ocular manifestations of the congenital varicella-zoster syndrome". Ophthalmologica. 205 (4): 191–3. PMID   1336591.
  27. Lloyd KM (1990). "Skin lesions as the sole manifestation of the fetal varicella syndrome". Arch Dermatol. 126 (4): 546–7. PMID   2322006.
  28. Charles NC, Bennett TW, Margolis S (1977). "Ocular pathology of the congenital varicella syndrome". Arch Ophthalmol. 95 (11): 2034–7. PMID   411463.
  29. Cotlier E (1978). "Congenital varicella cataract". Am J Ophthalmol. 86 (5): 627–9. PMID   717518.
  30. Scheffer IE, Baraitser M, Brett EM (1991). "Severe microcephaly associated with congenital varicella infection". Dev Med Child Neurol. 33 (10): 916–20. PMID   1743417.
  31. Smith, Candice K.; Arvin, Ann M. (2009). "Varicella in the fetus and newborn". Seminars in Fetal and Neonatal Medicine. 14 (4): 209–217. doi:10.1016/j.siny.2008.11.008. ISSN   1744-165X.
  32. Scharf A, Scherr O, Enders G, Helftenbein E (1990). "Virus detection in the fetal tissue of a premature delivery with a congenital varicella syndrome. A case report". J Perinat Med. 18 (4): 317–22. PMID   2175786.
  33. 1 2 Sauerbrei, A.; Wutzler, P. (2006). "Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections". Medical Microbiology and Immunology. 196 (2): 95–102. doi:10.1007/s00430-006-0032-z. ISSN   0300-8584.
  34. Hartung J, Enders G, Chaoui R, Arents A, Tennstedt C, Bollmann R (1999). "Prenatal diagnosis of congenital varicella syndrome and detection of varicella-zoster virus in the fetus: a case report". Prenat Diagn. 19 (2): 163–6. PMID   10215075.
  35. Meyberg-Solomayer GC, Fehm T, Muller-Hansen I, Enders G, Poets C, Wallwiener D, et al. (2006). "Prenatal ultrasound diagnosis, follow-up, and outcome of congenital varicella syndrome". Fetal Diagn Ther. 21 (3): 296–301. doi:10.1159/000091360. PMID   16601342.
  36. Mouly F, Mirlesse V, Méritet JF, Rozenberg F, Poissonier MH, Lebon P, et al. (1997). "Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases". Am J Obstet Gynecol. 177 (4): 894–8. PMID   9369842.
  37. Pretorius DH, Hayward I, Jones KL, Stamm E (1992). "Sonographic evaluation of pregnancies with maternal varicella infection". J Ultrasound Med. 11 (9): 459–63. PMID   1337112.
  38. Hofmeyr GJ, Moolla S, Lawrie T (1996). "Prenatal sonographic diagnosis of congenital varicella infection--a case report". Prenat Diagn. 16 (12): 1148–51. doi:10.1002/(SICI)1097-0223(199612)16:12<1148::AID-PD7>3.0.CO;2-J. PMID   8994252.
  39. Hitchcock R, Birthistle K, Carrington D, Calvert SA, Holmes K (1995). "Colonic atresia and spinal cord atrophy associated with a case of fetal varicella syndrome". J Pediatr Surg. 30 (9): 1344–7. PMID   8523241.
  40. Verstraelen H, Vanzieleghem B, Defoort P, Vanhaesebrouck P, Temmerman M (2003). "Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome: correlation with pathology findings". Prenat Diagn. 23 (9): 705–9. doi:10.1002/pd.669. PMID   12975778.
  41. Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM (1976). "Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life". Pediatrics. 58 (5): 692–6. PMID   185578.
  42. Harish, Rekha; Jamwal, Ashu; Dang, Ketan (2009). "Congenital varicella syndrome/ vericella zoster virus VZV fetopathy". The Indian Journal of Pediatrics. 77 (1): 92–93. doi:10.1007/s12098-009-0259-y. ISSN   0019-5456.
  43. "Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)".
  44. Shrim A, Koren G, Yudin MH, Farine D, Maternal Fetal Medicine Committee (2012). "Management of varicella infection (chickenpox) in pregnancy". J Obstet Gynaecol Can. 34 (3): 287–92. PMID   22385673.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  45. Cohen A, Moschopoulos P, Maschopoulos P, Stiehm RE, Koren G (2011). "Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin". CMAJ. 183 (2): 204–8. doi:10.1503/cmaj.100615. PMC   3033924 . PMID   21262937.